In AML, MDSCs can suppress potent antitumor immune responses [157] and can suppress the function of CD8+ T cells via high expression of Arg1 and indoleamine-2,3-dioxygenase 1 (IDO) [158]. The gene discussed is ARG1; the disease is acute myeloid leukemia.